People

Clinuvel’s Board of Directors

Mr Stanley McLiesh

Roles - Chairman, member of the Remuneration and Nomination Committee and the Audit and Risk Committee

Qualifications - BEd

Joined CUV Board - 2002

Biography

Dr Philippe Wolgen

Roles - Managing Director and Chief Executive Officer, Non-voting member of the Audit and Risk Committee and the Remuneration and Nomination Committee

Qualifications - MBA, MD

Joined CUV Board - 2005

Biography

Mrs Brenda Shanahan

Roles - Non-Executive Director, Chair of the Audit and Risk Committee

Qualifications - BComm, FAICD, ASIA

Joined CUV Board - 2007

Other affiliations - Chair of St Vincent's Medical Research Institute in Melbourne; non-Executive Director of DMP Asset Management; non-Executive Director of Challenger Limited (ASX:CGF); and  Director of the Kimberley Foundation of Australia.

Biography

Mr Jack Wood

Role - Non-Executive Director, Chair of the Remuneration and Nomination Committee

Qualifications - BComm

Joined CUV Board - 2008

Other affiliations - Chairman of EnGene Corporation; and Director of QLT

Biography

Mr Elie Ishag

Roles - Non-Executive Director

Joined CUV Board - 2011

Other affiliations - Chairman European Investments & Developments Ltd

Biography

Board Committee roles

Remuneration and Nomination Committee Audit and Risk Committee

Mrs Brenda Shanahan

 

Chair

Dr Philippe Wolgen

Non-voting member

Non-voting member

Mr Stanley McLiesh

Member

Member

Mr Jack Wood

Chair

 

Mr Elie Ishag

 

 

Executive Management

Dr Dennis Wright

Role - Acting Chief Scientific Officer

Qualifications - BPharm, MSc, PhD

Biography

Mr Darren Keamy

Roles - Chief Financial Officer, Company Secretary

Qualifications - BComm, CPA

Biography

 

Note - Roles correct as at September 30, 2012.

Investors' Blog Posts

We've just released the first results from our vitiligo program which you can view online here. Following their release, we expect a number...

Read More

Clinuvel Non-Executive Director Brenda Shanahan has been honoured at The Australian Financial Review and Westpac Group Woman of Influence...

Read More

Since we publicly announced our vitiligo program in 2010, the entire Clinuvel team has aimed to gain a better understand this disease, its...

Read More

Related Webcasts

Taking on Vitiligo, a depigmentation disorder of the skin. In 2010, Clinuvel ventured into an area of dermatology where no other pharmaceut...

Watch now

Taking on Vitiligo, a depigmentation disorder of the skin. In 2010, Clinuvel ventured into an area of dermatology where no other pharmaceut...

Watch now

Taking on Vitiligo, a depigmentation disorder of the skin. In 2010, Clinuvel ventured into an area of dermatology where no other pharmaceut...

Watch now

Investor Spotlight